Citadel Advisors
ARTC

Citadel Advisors’s ARTHROCARE CORP ARTC Stock Holding History

Citadel Advisors’s Portfolio ARTC Stock Details ARTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-528,209
Closed -$25.5M – 8746
2014
Q1 		$25.5M Buy
528,209
+500,511
+1,807% +$23.7M 0.03% 695
2013
Q4 		$1.11M Sell
27,698
-22,555
-45% -$836K ﹤0.01% 3126
2013
Q3 		$1.79M Sell
50,253
-57,361
-53% -$2M ﹤0.01% 2515
2013
Q2 		$3.72M Buy
+107,614
New +$3.7M 0.01% 1851

Citadel Advisors's ARTC Position: Q2 2014 in Review

Citadel Advisors sold out of ARTHROCARE CORP (ARTC) in Q2 2014, closing a stake of 528,209 shares — an estimated $25.5M sold.

Citadel Advisors first reported a position in ARTC in Q2 2013 and held it in 4 quarters. The position peaked at $25.5M in Q1 2014. 0 funds tracked by Wall St. Rank hold ARTC as of Q2 2014.

  • Citadel Advisors reported no remaining ARTHROCARE CORP position as of Q2 2014 after selling out during the quarter.
  • Citadel Advisors sold 528,209 ARTHROCARE CORP shares in Q2 2014, an estimated $25.5M.
  • Citadel Advisors first reported a position in ARTHROCARE CORP in Q2 2013 and held it in 4 quarters.
  • Citadel Advisors's ARTHROCARE CORP position peaked at $25.5M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held ARTHROCARE CORP as of Q2 2014.

Based on Citadel Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.